1. Will other drugmakers end up with deals like Endo’s $10M opioid settlement? — AstraZeneca Imfinzi combo fails advanced lung cancer study — FDA says they were “lucky” with Novartis data manipulation controversy — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. What happened a year ago this week in biopharma? Regeneron’s Eylea approval, Novartis’ new ethics czar, Vertex’s Kalydeco, and Opidvo’s SCLC approval click to review and read a current update of the big stories from one year ago
    Dismiss Notice

Ipsen

Anonymous board for Ipsen

Sort By:
Title
Replies Views
Last Message ↓
  1. anonymous
    Replies:
    2
    Views:
    197
  2. anonymous
    Replies:
    15
    Views:
    3,963
  3. anonymous
    Replies:
    5
    Views:
    518
  4. anonymous
    Replies:
    0
    Views:
    320
  5. anonymous
    Replies:
    0
    Views:
    432
  6. anonymous
    Replies:
    0
    Views:
    359
  7. Ruth
    Replies:
    4
    Views:
    1,850
  8. anonymous
    Replies:
    5
    Views:
    4,267
  9. anonymous
    Replies:
    8
    Views:
    1,769
  10. anonymous
    Replies:
    1
    Views:
    1,688
  11. anonymous
    Replies:
    3
    Views:
    3,002
  12. anonymous
    Replies:
    4
    Views:
    3,137
  13. anonymous
    Replies:
    8
    Views:
    4,259
  14. anonymous
    Replies:
    5
    Views:
    2,426
  15. anonymous
    Replies:
    1
    Views:
    1,550
  16. anonymous
    Replies:
    2
    Views:
    1,949
  17. anonymous
    Replies:
    9
    Views:
    3,778
  18. anonymous
    Replies:
    22
    Views:
    9,313
  19. anonymous
    Replies:
    7
    Views:
    3,118
  20. anonymous
    Replies:
    13
    Views:
    3,781

Thread Display Options

Loading...